The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
11.07
-0.01 (-0.09%)
Aug 13, 2025, 4:00 PM - Market closed
The Joint Revenue
The Joint had revenue of $13.27M in the quarter ending June 30, 2025, with 5.24% growth. This brings the company's revenue in the last twelve months to $53.45M, up 277.36% year-over-year. In the year 2024, The Joint had annual revenue of $51.90M with 10.47% growth.
Revenue (ttm)
$53.45M
Revenue Growth
+277.36%
P/S Ratio
3.11
Revenue / Employee
$72,622
Employees
736
Market Cap
168.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51.90M | 4.92M | 10.47% |
| Dec 31, 2023 | 46.98M | -54.27M | -53.60% |
| Dec 31, 2022 | 101.25M | 21.24M | 26.55% |
| Dec 31, 2021 | 80.01M | 21.33M | 36.34% |
| Dec 31, 2020 | 58.68M | 10.23M | 21.12% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
JYNT News
- 4 days ago - The Joint Corp. (JYNT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges - GlobeNewsWire
- 21 days ago - The Joint Corp. to Host Conference Call on Thursday, August 7th to Discuss Second Quarter 2025 Results - GlobeNewsWire
- 5 weeks ago - The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region - GlobeNewsWire
- 6 weeks ago - The Joint Chiropractic Launches Official Mobile App on iOS and Android - PRNewsWire
- 7 weeks ago - The Joint Corp. Signs Binding Agreement to Sell 31 Corporate Clinics in Arizona and New Mexico and to Acquire Regional Developer Rights in the Northwest Region and Refranchises Five Corporate Clinics in the Kansas City Region, Tracking to Become Largest Pure Play Chiropractic Care Franchise System - GlobeNewsWire
- 2 months ago - The Joint Corp. Names Business Transformation and Growth Expert Scott J. Bowman Chief Financial Officer - GlobeNewsWire
- 2 months ago - The Joint Corp. Announces $5 Million Stock Repurchase Program - GlobeNewsWire